Sosido is committed to building knowledge sharing communities around multiple disease and specialty areas. Our growing network currently includes more than 20,000 clinicians and researchers from more than 40 healthcare groups from around the world. For more information about creating a community on Sosido, contact us.
Cell Therapy Transplant Canada (CTTC), previously the Canadian Blood and Marrow Transplant Group (CBMTG), is a multidisciplinary organization of physicians, nurses, pharmacists, laboratory technologists, researchers and others providing leadership and promoting excellence in patient care, research and education in the field of BMT.
The Canadian Association of Nurses in Oncology (CANO/ACIO) promotes oncology nursing excellence through practice, education, research, and leadership for the benefit of all Canadians, with a vision of being an international nursing leader in cancer control.
The Canadian Association of Pharmacy in Oncology (CAPhO) is the national forum for oncology pharmacists, technicians, pharmacy assistants and other health care professionals interested in oncology pharmacy.
The Canadian Association of General Practitioners in Oncology (CAGPO) unifies and promotes communication among General Practitioners in Oncology in tertiary care and primary care settings across Canada.
The Canadian Association of Psychosocial Oncology (CAPO) is an organization of professionals, clinicians, researchers, educators, and others dedicated to the understanding, treatment and study of the social, psychological, emotional, spiritual and quality-of-life aspects of cancer.
The Canadian Association of Radiation Oncology (CARO-ACRO) promotes the highest standards of patient care in the practice of radiation oncology, excellence in professional standards, radiation oncology research and education.
The Canadian Organization of Medical Physicists (COMP) is the voice for medical physics in Canada, representing professional physicists, scientists and academics at universities, hospitals, cancer centres, and government research facilities, with the goal to promote patient care excellence through medical physics.
The Canadian Donation and Transplantation Research Program (CDTRP) is a national research network which aims to fulfill every donation opportunity and turn transplantation into a cure, through innovative and multidisciplinary research.
The Alberta Transplant Institute (ATI) at the University of Alberta brings together clinicians, researchers, educators and policy-makers dedicated to advancing transplantation in Alberta and Canada, supporting clinical transplant care and moving cutting-edge research into improved patient outcomes.
C17 connects the sixteen pediatric hematology, oncology, and stem cell transplant programs across Canada, working to improve outcomes and quality of life for children and adolescents with cancer and serious blood disorders in Canada.
The Canadian Podiatric Medical Association (CPMA) is a non-profit organization working on behalf of Canada’s premier foot specialists, dedicated to enhancing the profession of podiatry and increasing awareness among Canadians about the importance of good foot health care. CPMA’s participation in Sosido has been supported by a grant from Dr. Scholl’s®.
The Canadian Hemoglobinopathy Association/ L’Association canadienne d’hémoglobinopathie (CanHaem) is a not-for-profit organization for healthcare professionals and researchers in the field of Sickle Cell Disease and Thalassemia, dedicated to the care of individuals across Canada with Hemoglobinopathies.
The Centre hospitalier de l’université de Montréal (CHUM) Radiation Oncology Department includes radiation oncologists, technologists, physicists, nurses, nutritionists, psychologists and other health workers providing clinical consultation services, inpatient and outpatient curative and palliative treatment using cutting edge technologies.
Cross Cancer Institute is the comprehensive cancer centre for northern Alberta, and is one of two tertiary cancer centres in the province. The Cross Cancer Institute is a lead centre for the province-wide prevention, research and treatment program.
The Alberta Health Services Provincial Palliative Care Tumour Team (AHS Palliative Care Team) is a province-wide multidisciplinary team that includes surgeons, radiation oncologists, medical oncologists, nurses, psychosocial oncology, and others who work together to provide patients with relief from the symptoms, pain, physical stress and mental stress for people with late-stage cancer.
CancerCare Manitoba is the provincially mandated cancer agency tasked with providing cancer services to the people of Manitoba, responsible for providing care, treatment and support across the entire cancer service spectrum – from prevention, early detection, diagnosis, treatment and care, and palliation or end of life care.
BC Cancer – Kelowna (Sindi Ahluwalia Hawkins Centre for the Southern Interior) promotes cancer research, education, prevention, diagnosis and treatment, serving people from the Boundary, Cariboo, Kootenay, Okanagan, Similkameen and Thompson regions of British Columbia, Canada.
HIVE (Health Innovation Virtual Engagement) is a cross-specialty learning community for Canadian physicians, to support collaboration and enhance understanding of the condition of urticaria. Financial support for HIVE has been provided by Novartis Canada.
SIOP, the International Society of Paediatric Oncology, is a global organisation of doctors, nurses, other health-care professionals, scientists and other researchers, dedicated to increasing knowledge about all aspects of childhood cancer with the aim to improve and optimise treatments throughout the world.
The International Society of Paediatric Surgical Oncology (IPSO) is a global society of surgeons from over 50 countries, who specialise in the surgical care of children with cancer, with the goal to standardize and improve outcomes in the treatment of children with cancer around the world.
The International Society of Oncology Pharmacy Practitioners (ISOPP) exists to advance oncology pharmacy care for patients around the world, connecting Oncology Pharmacy experts from more than 30 countries to leading edge oncology knowledge, best practices and essential networks.
The Global Network for Spirituality and Health (GNSAH) connects clinicians and researchers around the world, to enhance the provision of high quality comprehensive and compassionate care to patients and families globally through the integration of spirituality into health systems. GNSAH is based out of the GW Institute of Spirituality and Health (GWISH) at George Washington University.
The Cancer Nurses Society of Australia (CNSA) is committed to achieving and promoting excellence in cancer care through the professional contribution of nurses through education, information, leadership, networking and professionalism. CNSA’s participation in Sosido is made possible by financial support from Roche Australia.
Société Française des Cancers et des leucémies de l’Enfant et de l’adolescent (SFCE) is an association of health professionals (surgeons, radiation oncologists, radiologists, pathologists, biologists, nurses and researchers) from 30 expert centres across France, dedicated to improving understanding, diagnosis, treatment and follow-up of cancers in children and adolescents.
The Lady Davis Institute (LDI) is the research arm of Montreal’s Jewish General Hospital, a teaching hospital of McGill University. It is among Canada’s leading medical research institutions, with major fields of inquiry include cancer, hemovascular diseases, epidemiology, diseases of aging, HIV/AIDS, and psychosocial science.
FLUID [Flexible Learning Urinary Incontinence Discipline] is a learning community for Canadian urologists and urogynecologists to support collaboration and enhance understanding of urinary incontinence (UI) and its therapeutic options. The FLUID community is made possible with financial support from AbbVie Corporation.
The Histiocyte Society is a nonprofit organization of more than 200 physicians and scientists from around the world committed to improving the lives of patients with histiocytic disorders by conducting clinical and laboratory research into the causes and treatments of this disease.